Narrow search
Showing 1 - 10 of 36,772
Cover Image
QALY maximization and the social optimum
López i Casasnovas, Guillem; Pinto Prades, José Luis - In: Hacienda pública española : review of public economics 242 (2022) 3, pp. 111-127
Persistent link: https://www.econbiz.de/10014276066
Cover Image
Der Wert besserer Gesundheit
Klose, Thomas - 2002
Persistent link: https://www.econbiz.de/10001626224
Cover Image
Utility independence in health profiles : an empirical study
Guerrero, Ana M.; Herrero Blanco, Carmen - In: Advances in public economics: utility, choice and …, (pp. 135-150). 2005
Persistent link: https://www.econbiz.de/10003214689
Cover Image
Costs of hospital care for strokes in India : a scoping review
Benedetto, Valerio; Cadilhac, Dominique A.; Spencer, Joseph - In: The Indian economic journal 71 (2023) 5, pp. 864-877
Persistent link: https://www.econbiz.de/10014425578
Cover Image
Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY
Nord, Erik; Johansen, Rune - In: Health Policy 116 (2014) 2, pp. 281-288
graded willingness to pay for a QALY. …
Persistent link: https://www.econbiz.de/10010776772
Cover Image
Applying the three core concepts of economic evaluation in health to education in the UK
Hinde, Sebastian; Walker, Simon; Lortie-Forgues, Hugues - 2019
Persistent link: https://www.econbiz.de/10012200828
Cover Image
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
Cai, Dan; Shi, Si; Jiang, Shan; Si, Lei; Wu, Jing; … - In: The European journal of health economics 23 (2022) 4, pp. 607-615
Persistent link: https://www.econbiz.de/10013279188
Cover Image
Cost-effectiveness of encorafenib with binimetinib in unresectable or metastatic BRAF-mutant melanoma
Trouiller, Jean-Baptiste; Nikolaidis, Georgios F.; … - In: The European journal of health economics 25 (2024) 4, pp. 641-653
Persistent link: https://www.econbiz.de/10014565059
Cover Image
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness : economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
Li, Xiao; Bilcke, Joke; Velden, Alike Wilhelmina van der; … - In: The European journal of health economics 24 (2023) 6, pp. 909-922
Persistent link: https://www.econbiz.de/10014328147
Cover Image
Cost-effectiveness analysis of the surgical treatment of female urinary incontinence using slings
Montesino-Semper, Manuel F.; Jiménez-Calvo, Jesús M.; … - Departamento de Economía - Universidad Pública de Navarra - 2013
month and 1 year post-operation to calculate the utility, using qualityadjusted life years (QALY), and the effectiveness …Objective. To determine the cost-utility and cost-effectiveness of the surgical treatment of female urinary … post-operation was 1,220€. The QALY achieved at 1 year was 0.046. The results reveal an ICER at 1 year of 26,288 €/QALY …
Persistent link: https://www.econbiz.de/10011147871